サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1552469

創薬サービスの世界市場：2033年までの機会と戦略

Drug Discovery Services Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 323 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
創薬サービスの世界市場：2033年までの機会と戦略
出版日: 2024年09月05日
発行: The Business Research Company
ページ情報: 英文 323 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の創薬サービス市場は2018年に99億2,330万米ドルと評価され、CAGR10.0％以上で2023年まで成長しました。

医薬品研究開発（R&D）への投資の増加

研究開発に対する製薬企業への投資の増加は、歴史的な期間における創薬サービス市場の成長を牽引しました。製薬企業は、技術革新と医療格差への対応のため、研究開発（R&D）に多額の投資をしました。製薬支出の増加は、研究能力、先端技術、広範な臨床試験を後押ししました。こうした投資により、新規治療や革新的治療への注目が高まり、専門的な創薬サービスへの需要が高まりました。前臨床試験と臨床試験のサポートは、投資を具体的な医学的進歩に変える上で重要な役割を果たしました。例えば、製薬業界の企業を代表する米国の業界団体である米国研究製薬工業協会（PhRMA）が実施した2022年会員年次調査によると、PhRMA会員企業は2021年に研究開発に1,023億米ドルを投資し、過去最高水準を記録しました。2022年の調査では、売上の約20％を研究開発に充てていることが明らかになった。PhRMA会員企業の支出は、2020年に米国バイオ医薬品業界全体が研究開発に費やした1,222億米ドルの大半を占める。さらに、2022年には世界の製薬企業全体で1,390億米ドルが研究開発に費やされます。したがって、医薬品の研究開発への投資の増加が創薬サービス市場の成長を支えています。

目次

第1章 エグゼクティブサマリー

  • 創薬サービス-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 創薬サービス市場定義とセグメンテーション
  • 市場セグメンテーション：タイプ別
    • 化学サービス
    • 生物学サービス
  • 市場セグメンテーション：プロセス別
    • ターゲットの選択
    • ターゲット検証
    • リードジェネレーションの識別
    • リード最適化
    • 候補者の検証
    • その他のプロセス
  • 市場セグメンテーション：薬剤タイプ別
    • 生物学的製剤
    • 低分子医薬品
  • 市場セグメンテーション：エンドユーザー別
    • 製薬およびバイオテクノロジー企業
    • 学術機関
    • その他のエンドユーザー

第7章 主要な市場動向

  • より迅速かつ効率的な創薬のためのAI駆動型ツールの統合
  • 創薬に革命をもたらす先進的なロボットと自動化技術
  • 最先端の計算技術で医薬品開発を変革
  • バイオテクノロジー産業の強化に向けた包括的な創薬ソリューション
  • 主要プレーヤー間の戦略的パートナーシップとコラボレーション
  • 創薬、医療技術、デジタルヘルスを推進する生成AIマイクロサービスの立ち上げ

第8章 創薬サービス市場：マクロ経済シナリオ

  • COVID-19の影響：創薬サービス市場
  • ウクライナ戦争の影響：創薬サービス市場
  • 高インフレの影響：創薬サービス市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因, 2018-2023
    • 市場抑制要因, 2018-2023
  • 市場成長予測, 2023-2028, 2033F
    • 市場促進要因, 2023-2028
    • 市場抑制要因, 2023-2028

第10章 世界の創薬サービス市場：セグメンテーション

  • 世界の創薬サービス市場：タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の創薬サービス市場：薬剤タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の創薬サービス市場：プロセス別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の創薬サービス市場：エンドユーザー別、実績と予測, 2018-2023, 2028F, 2033F

第11章 創薬サービス市場：地域・国別分析

  • 世界の創薬サービス市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の創薬サービス市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Charles River Laboratories International, Inc
  • Thermo Fisher Scientific Inc
  • Laboratory Corporation of America Holdings（Labcorp）
  • Evotec SE
  • Eurofins Scientific SE
  • Selvita S.A.
  • Proteros Biostructures GmbH
  • Axxam S.p.A
  • Enamine Ltd

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • Selvita Acquired PozLab
  • Ampersand Biomedicines Acquired AbCheck
  • Recursion Pharmaceuticals Acquired Cyclica And Valence
  • Eurofins Discovery Acquired CALIXAR
  • Sygnature Discovery Acquired SB Drug Discovery
  • Charles River Laboratories International Acquired SAMDI Tech
  • Verseon Acquired Edammo
  • ZS Acquired Intomics A/S
  • Bayer Acquired Vividion Therapeutics
  • X-Chem Acquired IntelliSyn And AviSyn

第23章 機会と戦略

  • 世界の創薬サービス市場、2028：新たな機会を提供する国
  • 世界の創薬サービス市場、2028：新たな機会を提供するセグメント
  • 世界の創薬サービス市場、2028：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第24章 創薬サービス市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第25章 付録

目次
Product Code: o&s1326

Drug discovery services refer to the range of activities and expertise provided by specialized companies to assist pharmaceutical and biotechnology firms in discovering new drugs. Drug discovery services are essential in the pharmaceutical industry, focusing on the early stages of drug development to identify and validate potential drug candidates.

The drug discovery services market consists of sales, by entities (organizations, sole traders and partnerships), of drug discovery services that encompass various scientific and technical services aimed at accelerating the discovery process, enhancing efficiency and reducing costs for drug developers.

The global drug discovery services market was valued at $9,923.30 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 10.0%.

Increased Investments In Pharmaceutical Research And Development (R&D)

The increased investments in pharmaceutical spending on research and development drove the growth of the drug discovery services market during the historic period. Pharmaceutical firms invested significantly in research and development (R&D) to innovate and address medical gaps. Increased pharmaceutical spending boosted research capabilities, advanced technologies and extensive clinical trials. This investment drove a focus on novel therapies and innovative treatments, raising demand for specialized drug discovery services. Preclinical testing and clinical trial support played a vital role in converting investment into tangible medical advancements. For example, according to the 2022-member annual survey conducted by Pharmaceutical Research and Manufacturers of America (PhRMA), a US-based trade group representing companies in the pharmaceutical industry, PhRMA member companies set a record by investing $102.3 billion in R&D in 2021, marking the highest level of investment ever. The 2022 survey revealed that approximately 20% of their revenue was dedicated to R&D. PhRMA members' spending constitutes the majority of the $122.2 billion spent by the entire US biopharmaceutical industry on R&D in 2020. Additionally, the global pharmaceutical companies collectively spent $139 billion on research and development in 2022. Therefore, the increased investments in pharmaceutical research and development supported the growth of the drug discovery services market.

Advanced Robotic And Automation Technologies For Revolutionizing Drug Discovery

Players in the drug discovery services market are leveraging advanced robotics and automation technologies to enhance efficiency and precision. These innovations streamline target identification, compound screening and lead optimization. High-throughput screening accelerates compound testing, while automated systems ensure accurate synthesis and purification. This integration reduces development time and costs, fostering the discovery of innovative therapeutics. For example, in January 2023, Insilico Medicine, a Hong Kong-based biotechnology company that provides drug discovery services, launched its 6th generation Intelligent Robotics Lab in Suzhou, China, to expedite its AI-driven drug discovery process. The lab employs advanced robotics and automation to streamline drug discovery stages, spanning from target identification to lead optimization. It features automated, high-throughput screening for rapid compound testing against drug targets and robotic systems for compound synthesis and purification, facilitating the creation of novel drug candidates.

The global drug discovery services market is concentrated, with large players operating in the market. The top ten competitors in the market made up 32.9% of the total market in 2023.

Drug Discovery Services Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global drug discovery services market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for drug discovery services? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drug discovery services market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider drug discovery services market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by process, by drug type and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the drug discovery services market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by process, by drug type and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for drug discovery services providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Chemistry Services; Biology Services
  • 2) By Process: Target Selection; Target Validation; Hit-To-Lead Identification; Lead Optimization; Candidate Validation; Other Processes
  • 3) By End User: Pharmaceutical; Biotechnology Companies; Academic Institutes; Other End Users
  • 4) By Drug Type: Biologics Drug; Small Molecule Drug
  • Companies Mentioned: Charles River Laboratories International, Inc.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Evotec SE; Eurofins Scientific SE
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; drug discovery services indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Drug Discovery Services - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Drug Discovery Services Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Chemistry Services
    • 6.4.2 Biology Services
  • 6.5 Market Segmentation By Process
    • 6.5.1 Target Selection
    • 6.5.2 Target Validation
    • 6.5.3 Hit-To-Lead Identification
    • 6.5.4 Lead Optimization
    • 6.5.5 Candidate Validation
    • 6.5.6 Other Processes
  • 6.6 Market Segmentation By Drug Type
    • 6.6.1 Biologics Drug
    • 6.6.2 Small Molecule Drug
  • 6.7 Market Segmentation By End User
    • 6.7.1 Pharmaceutical And Biotechnology Companies
    • 6.7.2 Academic Institutes
    • 6.7.3 Other End Users

7 Major Market Trends

  • 7.1 Integration Of AI-Driven Tools For Faster And More Efficient Drug Discovery
  • 7.2 Advanced Robotic And Automation Technologies For Revolutionizing Drug Discovery
  • 7.3 Transforming Drug Development With Cutting-Edge Computational Technologies
  • 7.4 Comprehensive Drug Discovery Solutions For Enhanced Biotech Industry Support
  • 7.5 Strategic Partnerships And Collaborations Among Major Players
  • 7.6 Launch Of Generative AI Microservices To Advance Drug Discovery, Medtech And Digital Health

8 Drug Discovery Services Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Drug Discovery Services Market
  • 8.2 Impact Of The War In Ukraine On The Drug Discovery Services Market
  • 8.3 Impact Of High Inflation On The Drug Discovery Services Market

9 Global Market Size And Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Drug Discovery Services Market Segmentation

  • 10.1 Global Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Drug Discovery Services Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Drug Discovery Services Market, Regional and Country Analysis

  • 11.1 Global Drug Discovery Services Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Drug Discovery Services Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Drug Discovery Services Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Drug Discovery Services Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Drug Discovery Services Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 199
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Drug Discovery Services Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 212
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.3 Regulatory Bodies
    • 15.7.7 Major Associations
    • 15.7.8 Taxes Levied
    • 15.7.9 Corporate Tax Structure
    • 15.7.10 Investments
    • 15.7.11 Major Companies
  • 15.8 USA Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 231
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Drug Discovery Services Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 263
    • 18.1.3 263
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Charles River Laboratories International, Inc
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Thermo Fisher Scientific Inc
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Laboratory Corporation of America Holdings (Labcorp)
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Evotec SE
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Eurofins Scientific SE
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview
  • 19.6 Selvita S.A.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview
  • 19.7 Proteros Biostructures GmbH
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
    • 19.7.3 Business Strategy
    • 19.7.4 Financial Overview
  • 19.8 Axxam S.p.A
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
    • 19.8.3 Business Strategy
    • 19.8.4 Financial Overview
  • 19.9 Enamine Ltd
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
    • 19.9.3 Business Strategy
    • 19.9.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Selvita Acquired PozLab
  • 22.2 Ampersand Biomedicines Acquired AbCheck
  • 22.3 Recursion Pharmaceuticals Acquired Cyclica And Valence
  • 22.4 Eurofins Discovery Acquired CALIXAR
  • 22.5 Sygnature Discovery Acquired SB Drug Discovery
  • 22.6 Charles River Laboratories International Acquired SAMDI Tech
  • 22.7 Verseon Acquired Edammo
  • 22.8 ZS Acquired Intomics A/S
  • 22.9 Bayer Acquired Vividion Therapeutics
  • 22.10 X-Chem Acquired IntelliSyn And AviSyn

23 Opportunities And Strategies

  • 23.1 Global Drug Discovery Services Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Drug Discovery Services Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Drug Discovery Services Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Drug Discovery Services Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer